Xylutide Enzalutamide – 40 mg (1 pack / 28 capsules)

At a Glance

Brand name: Xylutide

Generic name: Enzalutamide

Active ingredient: Enzalutamide

Strength & pack size: Xylutide 40 mg (1 pack / 28 capsules)

Dosage form: Oral hard capsules

Main indication: Advanced and metastatic castration-resistant prostate cancer and other androgen-driven settings as indicated

Therapeutic class: Androgen receptor inhibitor (hormonal anticancer therapy)

Use in therapy: Systemic oral treatment alongside ongoing androgen deprivation therapy (ADT)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Xylutide 40 mg capsules are a generic enzalutamide medicine used in the treatment of advanced and metastatic
prostate cancer. Enzalutamide is a potent oral androgen receptor inhibitor that blocks androgen-driven signalling
inside prostate cancer cells. Xylutide 40 mg (1 pack / 28 capsules) provides a convenient weekly supply of
enzalutamide 40 mg capsules that matches your specialist’s written treatment plan.

In many protocols, enzalutamide is used for metastatic castration-resistant prostate cancer (mCRPC) and in other settings such as
metastatic castration-sensitive or non-metastatic castration-resistant disease, according to recognised guidelines.
Because Xylutide is a generic enzalutamide product, it contains the same active ingredient as branded enzalutamide while offering more accessible pricing in USD
for long-term hormonal therapy.

A typical adult daily dose is 160 mg, often given as four Xylutide 40 mg capsules once daily, although your oncology or urology team may adjust this.
The pack of Xylutide 40 mg (1 pack / 28 capsules) may correspond to a seven-day supply at 160 mg per day or a longer course at reduced doses.
Treatment with Xylutide enzalutamide is usually combined with continuous androgen deprivation therapy (ADT) using LHRH analogues or after surgical castration.

When you buy Xylutide 40 mg online from Generic Meds Mart, you receive generic enzalutamide capsules supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy, while original blisters and cartons preserve all product details such as strength, batch number and expiry date.

This Xylutide 40 mg enzalutamide product is intended only for patients under specialist oncology or urology care.
Generic Meds Mart does not diagnose cancer or alter treatment plans; the information here supports informed discussions with your treating team about access to
generic enzalutamide capsules.

Key Uses

Xylutide 40 mg enzalutamide capsules are generally used for the following indications under specialist supervision:

• Treatment of metastatic castration-resistant prostate cancer (mCRPC) alongside continuous androgen deprivation therapy
• Treatment of metastatic castration-sensitive or non-metastatic castration-resistant prostate cancer in selected patients according to recognised guidelines
• Continuation or switch therapy in men previously treated with other hormonal agents or chemotherapy when an androgen receptor inhibitor is recommended

Your specialist will determine whether Xylutide 40 mg is appropriate, how it fits into your overall treatment plan and how long
enzalutamide therapy should continue.

How Enzalutamide Works in Chemotherapy

Enzalutamide is an oral hormonal anticancer agent often grouped within modern systemic chemotherapy and targeted hormonal regimens.
Xylutide 40 mg contains enzalutamide, an androgen receptor inhibitor that blocks androgen-driven signalling in
prostate cancer cells.

In androgen-dependent prostate cancer, hormones such as testosterone and dihydrotestosterone bind to androgen receptors, which then move into the cell nucleus and activate genes that promote tumour growth and survival.
Xylutide enzalutamide capsules act at several stages of this process: they bind to the androgen receptor with high affinity, prevent androgen binding, reduce nuclear translocation and limit DNA binding and gene activation.
By disrupting androgen receptor signalling, Xylutide 40 mg can slow tumour growth, lower PSA levels and delay complications of advanced prostate cancer.

Although more targeted than many traditional cytotoxic agents, enzalutamide still has systemic effects and can influence the nervous system, blood pressure and liver function.
Careful monitoring by an experienced oncologist or urologist is therefore essential during Xylutide enzalutamide therapy.

Dosage & Administration

Xylutide 40 mg enzalutamide capsules must always be taken exactly as prescribed by your specialist.
Daily dosing, treatment duration and any dose changes depend on your diagnosis, other medicines and how you tolerate therapy.

• Take Xylutide capsules by mouth once daily, with or without food, at approximately the same time each day.
• Swallow Xylutide 40 mg capsules whole with water; do not open, crush or chew them unless your doctor or pharmacist gives specific instructions.
• Continue concurrent androgen deprivation therapy (ADT) unless your doctor has already performed surgical castration and advised otherwise.
• Do not change your dose, skip doses or stop taking Xylutide without clear guidance from your oncology or urology team.
• If you miss a dose, follow your doctor’s instructions; do not take extra capsules to compensate unless specifically advised.

Your specialist will schedule regular visits, PSA tests, blood pressure checks and other investigations to monitor your response to
Xylutide enzalutamide and to adjust treatment as needed.

Precautions

Before starting Xylutide 40 mg, inform your doctor about your full medical history and all medicines, supplements and herbal products you use. Important considerations include:

• History of seizures, epilepsy, brain injury, stroke or conditions that increase seizure risk
• Cardiovascular disease, high blood pressure, heart failure or rhythm disturbances
• Pre-existing liver impairment or significant hepatic disease
• Previous falls, fractures or conditions affecting bone strength or balance
• Use of strong CYP2C8 or CYP3A4 inhibitors or inducers and medicines with a narrow therapeutic index
• Use of over-the-counter products or herbal remedies that may interact with enzalutamide

Enzalutamide is not intended for use in women and may harm an unborn baby. Men taking Xylutide 40 mg are usually advised to use effective contraception if their partner may become pregnant, both during treatment and for a period afterwards, as directed by their doctor.

Enzalutamide Side Effects

Common side effects

Many patients experience side effects when starting Xylutide enzalutamide capsules, especially during the first months of therapy. Common reactions may include:

• Fatigue, low energy or general tiredness
• Hot flushes
• Increased blood pressure or worsening of existing hypertension
• Headache, dizziness or difficulty concentrating
• Back pain, joint pain or muscle discomfort
• Mild swelling of the hands, ankles or feet
• Mild diarrhea, nausea or reduced appetite

These side effects are often manageable with supportive care or adjustments in overall management, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of enzalutamide are less common but serious and require urgent medical attention. Serious reactions may include:

• Seizures, sudden loss of consciousness or unusual movements
• Severe confusion, strong headache or visual changes
• Very high blood pressure, chest pain or shortness of breath suggesting a cardiovascular event
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Repeated falls, new fractures or sudden severe bone pain

If you experience any of these serious symptoms while taking Xylutide 40 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Xylutide 40 mg capsules at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the capsules in their original blisters and carton until use to protect them from moisture and light.
• Keep enzalutamide capsules out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Xylutide enzalutamide capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Xylutide 40 mg enzalutamide capsules at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Xylutide 40 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic enzalutamide capsules compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist or urologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed hormonal therapy with transparent conditions and professional handling of each order.

Order Now

Xylutide 40 mg enzalutamide capsules are prescription-only anticancer medicines and must be used strictly under the supervision of an experienced oncologist or urologist.
Before you order Xylutide 40 mg online, ensure that you have a valid prescription or written treatment plan specifying enzalutamide, the daily dose and the intended duration of therapy.

Select Xylutide 40 mg (1 pack / 28 capsules), choose the appropriate quantity, add Xylutide to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your healthcare team.

Samtica 250 mg Abiraterone Tablets (1 pack / 120 tabs)

At a Glance

Generic Name: Abiraterone Acetate

Brand Name: Samtica 250 mg

Strength & Pack Size: 250 mg tablets, 1 pack / 120 tablets

Dosage Form & Route: Oral film-coated tablets for swallowing whole

Therapeutic Class: Androgen biosynthesis inhibitor (selective CYP17 inhibitor)

Primary Indications: Metastatic castration-resistant and high-risk metastatic hormone-sensitive prostate cancer, as per local label

Typical Use in Therapy: Given once daily with prednisone or prednisolone on top of ongoing androgen-deprivation therapy

Mode of Action: Selectively inhibits CYP17 to reduce androgen production from testes, adrenals and tumour tissue

Key Benefits: Proven improvement in survival, disease control and symptom burden in carefully selected prostate cancer patients

Precautions: Requires monitoring of liver function, blood pressure, potassium and fluid status; contraindicated in pregnancy and used only in men

Storage: Store below 25 °C in the original blister, protected from moisture and out of children’s reach

Product Description

Samtica 250 mg contains abiraterone acetate, an oral androgen biosynthesis inhibitor used for the treatment of advanced prostate cancer under specialist oncology or uro-oncology supervision. Abiraterone works by selectively inhibiting CYP17, a key enzyme in androgen production, thereby reducing testosterone and other androgens not only from the testes but also from the adrenal glands and within prostate cancer tissue itself.

Each pack of Samtica 250 mg supplied by Generic Meds Mart contains 120 film-coated tablets, designed to be used as part of continuous daily therapy alongside low-dose prednisone or prednisolone and ongoing androgen-deprivation therapy (such as surgical castration or LHRH agonists/antagonists). Depending on your local label and protocol, one pack may correspond to around one month of treatment at the standard daily dose.

Samtica 250 mg abiraterone tablets are typically used either in metastatic castration-resistant prostate cancer, where disease has progressed despite castrate levels of testosterone, or in high-risk metastatic hormone-sensitive prostate cancer, where early intensification improves outcomes. The decision to use abiraterone, and for how long, is always made by a specialist team based on disease stage, comorbidities, prior treatments, access to alternatives and patient preferences. Generic Meds Mart does not replace medical advice; our role is limited to sourcing original Samtica 250 mg packs and managing international logistics where regulations allow.

Generic Meds Mart works only with licensed manufacturers and authorised distributors for Samtica 250 mg. Packs are delivered in original, sealed oncology packaging with visible batch numbers and expiry dates so oncology pharmacies can verify authenticity before dispensing. Outer shipping cartons remain neutral, without visible references to prostate cancer or abiraterone, to preserve patient privacy. Prices are displayed in USD, helping clinics and patients plan the cost of long-term therapy.

Key Uses

Samtica 250 mg abiraterone tablets are used in standard guideline-based prostate cancer treatment indications, which may include:

• Metastatic castration-resistant prostate cancer (mCRPC) in men whose disease has progressed on androgen-deprivation therapy, often with or without prior chemotherapy, depending on local label and clinical situation.
• High-risk metastatic hormone-sensitive prostate cancer (mHSPC), where early intensification of systemic therapy with abiraterone plus steroids has been shown to improve survival and delay complications in appropriate patients.
• Selected patients with advanced disease where abiraterone-based therapy is considered clinically appropriate by the specialist team, in line with regional approvals and reimbursement rules.

The choice between abiraterone (Samtica 250 mg), chemotherapy, other androgen receptor–targeted agents or combinations is individualised and should always follow specialist recommendations based on evidence and patient-specific factors.

How Abiraterone Works in Chemotherapy

Although abiraterone is not a traditional cytotoxic chemotherapy, it is often discussed within the broader systemic treatment options for advanced prostate cancer. Abiraterone acetate, the active component of Samtica 250 mg, is converted in the body to abiraterone, which selectively and irreversibly inhibits the enzyme CYP17 (17α-hydroxylase/C17,20-lyase).

CYP17 is critical in androgen biosynthesis pathways in the testes, adrenal glands and tumour tissue. By blocking this enzyme, abiraterone reduces the synthesis of androgens such as testosterone and dihydrotestosterone, which prostate cancer cells rely on for growth and survival, even in castrate conditions. The profound reduction of circulating and intratumoural androgens helps slow tumour progression, improve PSA responses, delay skeletal events and prolong survival when used appropriately in metastatic prostate cancer.

Because CYP17 inhibition also affects mineralocorticoid pathways, abiraterone leads to a rise in mineralocorticoids, which is why Samtica 250 mg must be co-administered with low-dose prednisone or prednisolone to reduce the risk of hypertension, fluid retention and hypokalaemia.

Dosage & Administration

Samtica 250 mg abiraterone tablets must be prescribed and monitored by an oncologist or uro-oncologist experienced in advanced prostate cancer. The usual total daily dose of abiraterone is defined in the product information and may be given as multiple 250 mg tablets taken once daily. Tablets are usually taken on an empty stomach (for example, at least two hours after and one hour before food), as food can significantly alter abiraterone exposure.

Samtica 250 mg is always used together with low-dose prednisone or prednisolone, taken according to the schedule specified by your doctor. Continuing androgen-deprivation therapy is usually required. Regular monitoring includes liver function tests, blood pressure, electrolytes (particularly potassium) and signs of fluid retention or heart failure. Dose interruptions, reductions or discontinuation may be needed if significant toxicity or biochemical abnormalities occur. Patients should never change their abiraterone or steroid dose without specialist guidance.

Precautions

Before starting Samtica 250 mg, your specialist will assess your liver function, cardiovascular status, blood pressure, potassium level and overall fitness for systemic prostate cancer therapy. Abiraterone can worsen hypertension, hypokalaemia and fluid retention, so caution is required in patients with heart failure, coronary disease or other cardiovascular risk factors.

Liver function tests are checked regularly, as abiraterone can cause elevations in liver enzymes and, rarely, serious hepatotoxicity. The medicine is contraindicated in women who are or may become pregnant, and Samtica 250 mg is intended only for use in men. Handling instructions should be followed carefully, particularly by caregivers. Effective contraception is recommended for men with partners who may become pregnant because abiraterone can harm an unborn baby.

Abiraterone Side Effects

Common side effects

Common abiraterone side effects seen in patients taking Samtica 250 mg include fluid retention, ankle swelling, increased blood pressure, low blood potassium, fatigue, joint or muscle pain, hot flushes, diarrhoea, indigestion, cough and mild liver enzyme elevations. Many patients also report mild urinary symptoms, changes in appetite or sleep disturbance.

These effects are often manageable with dose adjustments, diuretics, potassium supplementation, blood pressure medicines, lifestyle measures and careful monitoring. Your oncology team will explain which symptoms to expect and when to contact the clinic.

Serious side effects

Serious abiraterone adverse effects require urgent medical attention and may include severe liver dysfunction with marked jaundice or very high liver enzymes, dangerous hypokalaemia leading to muscle weakness or cardiac arrhythmias, worsening heart failure or severe fluid overload, uncontrolled hypertension, severe shortness of breath or sudden chest pain. Rarely, severe allergic reactions can occur.

Patients should seek immediate medical help if they develop sudden weight gain with swelling, severe breathlessness, chest pain, fainting, marked jaundice, dark urine, confusion, muscle cramps with pronounced weakness or any other alarming symptom while taking Samtica 250 mg with steroids.

Storage

Samtica 250 mg abiraterone tablets should be stored in the original blister and outer carton below 25 °C, protected from moisture and direct heat. The pack must be kept out of sight and reach of children and should not be stored in humid environments such as bathrooms. Tablets should not be used after the expiry date printed on the carton and blister. Unused or expired medicine should be returned to a pharmacy or disposed of according to local cytotoxic/oncology waste guidance, not flushed or thrown in household rubbish.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on structured access to key prostate cancer therapies such as Samtica 250 mg abiraterone tablets. We partner only with licensed manufacturers and authorised distributors that follow recognised Good Manufacturing Practice and maintain traceable batch records. Each pack of Samtica 250 mg is supplied in sealed original oncology packaging so your treatment centre can verify brand, strength, batch number and expiry before dispensing.

Prices are clearly shown in USD, helping patients and clinics plan the cost of long-term metastatic prostate cancer therapy. Orders are shipped in neutral outer packaging without obvious references to abiraterone or prostate cancer, and where available, tracking details are provided so you and your team can coordinate treatment scheduling around delivery. Our customer support can help with ordering and logistics questions, but treatment decisions remain strictly between you and your oncology specialists.

Order Now

Before you buy Samtica 250 mg abiraterone tablets online from Generic Meds Mart, you must have a clear treatment plan from your oncologist or uro-oncologist. This should describe your diagnosis, stage, prior therapies, the role of abiraterone in your regimen, how many Samtica 250 mg tablets you will take each day, the dose of prednisone or prednisolone, and how often blood tests and monitoring visits will be scheduled.

Once your plan is agreed, your team can estimate how many packs of Samtica 250 mg (1 pack / 120 tabs) you need for your initial treatment period. You can then select the required number of packs on Generic Meds Mart, add them to your cart and complete secure checkout in USD. Your medicine will be shipped in discreet packaging with full product labelling. You should never start, stop or change Samtica 250 mg or your steroid dose without consulting your specialist, and any new or severe symptoms should prompt immediate contact with your oncology team or emergency services.

FAQ about Samtica (Abiraterone)

Q1: What is Samtica 250 mg used for?
Samtica 250 mg contains abiraterone acetate, an androgen biosynthesis inhibitor used with prednisone or prednisolone and ongoing androgen-deprivation therapy in men with metastatic castration-resistant or high-risk metastatic hormone-sensitive prostate cancer, as permitted by local approvals and guidelines.

Q2: Do I still need hormone injections if I take Samtica 250 mg?
In most protocols, abiraterone (Samtica 250 mg) is given on top of ongoing androgen-deprivation therapy, such as LHRH agonists or antagonists or surgical castration. You should not stop hormone injections or change your regimen unless your specialist clearly instructs you to do so.

Q3: Why must I take steroids with Samtica 250 mg?
Abiraterone blocks CYP17 and reduces cortisol production, which in turn increases mineralocorticoids. Low-dose prednisone or prednisolone is prescribed with Samtica 250 mg to replace some steroid hormone and reduce the risk of high blood pressure, fluid retention and low potassium linked to mineralocorticoid excess.

Q4: Can I take Samtica 250 mg with food?
Abiraterone exposure is strongly affected by food. Samtica 250 mg tablets are usually taken on an empty stomach, for example at least two hours after eating and one hour before the next meal, exactly as directed in your product leaflet and by your specialist. You should follow the same routine each day and not change it without medical advice.

Q5: How long will I need to stay on Samtica 250 mg?
Treatment duration with Samtica 250 mg varies. Many patients continue abiraterone therapy as long as they are benefiting and side effects remain manageable, but therapy may be stopped if the cancer progresses or unacceptable toxicity develops. Your oncology team will monitor PSA, imaging, symptoms and blood tests and will decide with you when to continue, pause or switch treatment.

Indenza Enzalutamide – 40 mg (1 pack / 112 capsules)

At a Glance

Brand name: Indenza

Generic name: Enzalutamide

Active ingredient: Enzalutamide

Strength & pack size: Indenza 40 mg (1 pack / 112 capsules)

Dosage form: Oral hard capsules

Main indication: Advanced and metastatic castration-resistant prostate cancer and other androgen-driven settings as indicated

Therapeutic class: Androgen receptor inhibitor (hormonal anticancer therapy)

Use in therapy: Systemic oral treatment alongside ongoing androgen deprivation therapy (ADT)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Indenza 40 mg capsules are a generic enzalutamide medicine used in the treatment of advanced and metastatic
prostate cancer. Enzalutamide is a potent oral androgen receptor inhibitor that blocks androgen-driven signalling
inside prostate cancer cells. Indenza 40 mg (1 pack / 112 capsules) provides a larger monthly supply of
enzalutamide 40 mg capsules that can match your specialist’s written treatment plan.

In many protocols, enzalutamide is used for metastatic castration-resistant prostate cancer (mCRPC) and in other settings such as
metastatic castration-sensitive or non-metastatic castration-resistant disease, according to recognised guidelines.
Because Indenza is a generic enzalutamide product, it contains the same active ingredient as branded enzalutamide while offering more accessible pricing in USD
for long-term hormonal therapy.

A typical adult daily dose is 160 mg, often given as four Indenza 40 mg capsules once daily, although your oncology or urology team may adjust this.
The pack of Indenza 40 mg (1 pack / 112 capsules) usually corresponds to a 28-day supply at 160 mg per day.
Treatment with Indenza enzalutamide is usually combined with continuous androgen deprivation therapy (ADT) using LHRH analogues or after surgical castration.

When you buy Indenza 40 mg online from Generic Meds Mart, you receive generic enzalutamide capsules supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy, while original blisters and cartons preserve all product details such as strength, batch number and expiry date.

This Indenza 40 mg enzalutamide product is intended only for patients under specialist oncology or urology care.
Generic Meds Mart does not diagnose cancer or alter treatment plans; the information here supports informed discussions with your treating team about access to
generic enzalutamide capsules.

Key Uses

Indenza 40 mg enzalutamide capsules are generally used for the following indications under specialist supervision:

• Treatment of metastatic castration-resistant prostate cancer (mCRPC) alongside continuous androgen deprivation therapy
• Treatment of metastatic castration-sensitive or non-metastatic castration-resistant prostate cancer in selected patients according to recognised guidelines
• Continuation or switch therapy in men previously treated with other hormonal agents or chemotherapy when an androgen receptor inhibitor is recommended

Your specialist will determine whether Indenza 40 mg is appropriate, how it fits into your overall treatment plan and how long
enzalutamide therapy should continue.

How Enzalutamide Works in Chemotherapy

Enzalutamide is an oral hormonal anticancer agent often grouped within modern systemic chemotherapy and targeted hormonal regimens.
Indenza 40 mg contains enzalutamide, an androgen receptor inhibitor that blocks androgen-driven signalling in
prostate cancer cells.

In androgen-dependent prostate cancer, hormones such as testosterone and dihydrotestosterone bind to androgen receptors, which then move into the cell nucleus and activate genes that promote tumour growth and survival.
Indenza enzalutamide capsules act at several stages of this process: they bind to the androgen receptor with high affinity, prevent androgen binding, reduce nuclear translocation and limit DNA binding and gene activation.
By disrupting androgen receptor signalling, Indenza 40 mg can slow tumour growth, lower PSA levels and delay complications of advanced prostate cancer.

Although more targeted than many traditional cytotoxic agents, enzalutamide still has systemic effects and can influence the nervous system, blood pressure and liver function.
Careful monitoring by an experienced oncologist or urologist is therefore essential during Indenza enzalutamide therapy.

Dosage & Administration

Indenza 40 mg enzalutamide capsules must always be taken exactly as prescribed by your specialist.
Daily dosing, treatment duration and any dose changes depend on your diagnosis, other medicines and how you tolerate therapy.

• Take Indenza capsules by mouth once daily, with or without food, at approximately the same time each day.
• Swallow Indenza 40 mg capsules whole with water; do not open, crush or chew them unless your doctor or pharmacist gives specific instructions.
• Continue concurrent androgen deprivation therapy (ADT) unless your doctor has already performed surgical castration and advised otherwise.
• Do not change your dose, skip doses or stop taking Indenza without clear guidance from your oncology or urology team.
• If you miss a dose, follow your doctor’s instructions; do not take extra capsules to compensate unless specifically advised.

Your specialist will schedule regular visits, PSA tests, blood pressure checks and other investigations to monitor your response to
Indenza enzalutamide and to adjust treatment as needed.

Precautions

Before starting Indenza 40 mg, inform your doctor about your full medical history and all medicines, supplements and herbal products you use. Important considerations include:

• History of seizures, epilepsy, brain injury, stroke or conditions that increase seizure risk
• Cardiovascular disease, high blood pressure, heart failure or rhythm disturbances
• Pre-existing liver impairment or significant hepatic disease
• Previous falls, fractures or conditions affecting bone strength or balance
• Use of strong CYP2C8 or CYP3A4 inhibitors or inducers and medicines with a narrow therapeutic index
• Use of over-the-counter products or herbal remedies that may interact with enzalutamide

Enzalutamide is not intended for use in women and may harm an unborn baby. Men taking Indenza 40 mg are usually advised to use effective contraception if their partner may become pregnant, both during treatment and for a period afterwards, as directed by their doctor.

Enzalutamide Side Effects

Common side effects

Many patients experience side effects when starting Indenza enzalutamide capsules, especially during the first months of therapy. Common reactions may include:

• Fatigue, low energy or general tiredness
• Hot flushes
• Increased blood pressure or worsening of existing hypertension
• Headache, dizziness or difficulty concentrating
• Back pain, joint pain or muscle discomfort
• Mild swelling of the hands, ankles or feet
• Mild diarrhea, nausea or reduced appetite

These side effects are often manageable with supportive care or adjustments in overall management, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of enzalutamide are less common but serious and require urgent medical attention. Serious reactions may include:

• Seizures, sudden loss of consciousness or unusual movements
• Severe confusion, strong headache or visual changes
• Very high blood pressure, chest pain or shortness of breath suggesting a cardiovascular event
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Repeated falls, new fractures or sudden severe bone pain

If you experience any of these serious symptoms while taking Indenza 40 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Indenza 40 mg capsules at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the capsules in their original blisters and carton until use to protect them from moisture and light.
• Keep enzalutamide capsules out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Indenza enzalutamide capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Indenza 40 mg enzalutamide capsules at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Indenza 40 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic enzalutamide capsules compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist or urologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed hormonal therapy with transparent conditions and professional handling of each order.

Order Now

Indenza 40 mg enzalutamide capsules are prescription-only anticancer medicines and must be used strictly under the supervision of an experienced oncologist or urologist.
Before you order Indenza 40 mg online, ensure that you have a valid prescription or written treatment plan specifying enzalutamide, the daily dose and the intended duration of therapy.

Select Indenza 40 mg (1 pack / 112 capsules), choose the appropriate quantity, add Indenza to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your healthcare team.

Glenza Enzalutamide – 40 mg (1 pack / 28 capsules)

At a Glance

Brand name: Glenza

Generic name: Enzalutamide

Active ingredient: Enzalutamide

Strength & pack size: Glenza 40 mg (1 pack / 28 capsules)

Dosage form: Oral hard capsules

Main indication: Advanced and metastatic castration-resistant prostate cancer and other androgen-driven settings as indicated

Therapeutic class: Androgen receptor inhibitor

Use in therapy: Systemic oral treatment alongside ongoing androgen deprivation therapy (ADT)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Glenza 40 mg capsules are a generic enzalutamide medicine used in the treatment of advanced and metastatic
prostate cancer. Enzalutamide is a potent oral androgen receptor inhibitor that blocks androgen-driven signalling
inside prostate cancer cells. Glenza 40 mg (1 pack / 28 capsules) provides a convenient supply of
enzalutamide 40 mg capsules that matches your specialist’s written treatment plan.

In many treatment protocols, enzalutamide is used in metastatic castration-resistant prostate cancer (mCRPC) and in other settings such as
metastatic castration-sensitive or non-metastatic castration-resistant disease, according to recognised guidelines.
Because Glenza is a generic enzalutamide product, it contains the same active ingredient as branded enzalutamide while offering more accessible pricing in USD
for long-term hormonal therapy.

A typical adult daily dose is 160 mg, often given as four Glenza 40 mg capsules once daily, although your oncology or urology team may adjust this.
The pack of Glenza 40 mg (1 pack / 28 capsules) may correspond to a seven-day supply at 160 mg per day or a longer course at reduced doses.
Treatment with Glenza enzalutamide is usually combined with continuous androgen deprivation therapy (ADT) using LHRH analogues or after surgical castration.

When you buy Glenza 40 mg online from Generic Meds Mart, you receive generic enzalutamide capsules supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy, while original blisters and cartons preserve all product details such as strength, batch number and expiry date.

This Glenza 40 mg enzalutamide product is intended only for patients under specialist oncology or urology care.
Generic Meds Mart does not diagnose cancer or alter treatment plans; the information here supports informed discussions with your treating team about access to
generic enzalutamide capsules.

Key Uses

Glenza 40 mg enzalutamide capsules are generally used for the following indications under specialist supervision:

• Treatment of metastatic castration-resistant prostate cancer (mCRPC) alongside ongoing androgen deprivation therapy
• Treatment of metastatic castration-sensitive or non-metastatic castration-resistant prostate cancer in selected patients according to recognised guidelines
• Continuation or switch therapy in men previously treated with other hormonal agents or chemotherapy when an androgen receptor inhibitor is recommended

Your specialist will determine whether Glenza 40 mg is appropriate, how it fits into your overall treatment plan and how long
enzalutamide therapy should continue.

How Enzalutamide Works in Chemotherapy

Enzalutamide is an oral hormonal anticancer agent often grouped within modern systemic chemotherapy and targeted hormonal regimens.
Glenza 40 mg contains enzalutamide, an androgen receptor inhibitor that blocks androgen-driven signalling in
prostate cancer cells.

In androgen-dependent prostate cancer, hormones such as testosterone and dihydrotestosterone bind to androgen receptors, which then move into the cell nucleus and activate genes that promote tumour growth and survival.
Glenza enzalutamide capsules act at several stages of this process: they bind to the androgen receptor with high affinity, prevent androgen binding, reduce nuclear translocation and limit DNA binding and gene activation.
By disrupting androgen receptor signalling, Glenza 40 mg can slow tumour growth, lower PSA levels and delay complications of advanced prostate cancer.

Although more targeted than many traditional cytotoxic agents, enzalutamide still has systemic effects and can influence the nervous system, blood pressure and other organs.
Careful monitoring by an experienced oncologist or urologist is therefore essential during Glenza enzalutamide therapy.

Dosage & Administration

Glenza 40 mg enzalutamide capsules must always be taken exactly as prescribed by your specialist.
Daily dosing, treatment duration and any dose changes depend on your diagnosis, other medicines and how you tolerate therapy.

• Take Glenza capsules by mouth once daily, with or without food, at approximately the same time each day.
• Swallow Glenza 40 mg capsules whole with water; do not open, crush or chew them unless your doctor or pharmacist gives specific instructions.
• Continue concurrent androgen deprivation therapy (ADT) unless your doctor has already performed surgical castration and advised otherwise.
• Do not change your dose, skip doses or stop taking Glenza without clear guidance from your oncology or urology team.
• If you miss a dose, follow your doctor’s instructions; do not take extra capsules to compensate unless specifically advised.

Your specialist will schedule regular visits, PSA tests, blood pressure checks and other investigations to monitor your response to
Glenza enzalutamide and to adjust treatment as needed.

Precautions

Before starting Glenza 40 mg, inform your doctor about your full medical history and all medicines, supplements and herbal products you use. Important considerations include:

• History of seizures, brain injury, stroke or conditions that increase seizure risk
• Cardiovascular disease, high blood pressure, heart failure or rhythm disturbances
• Pre-existing liver impairment or significant hepatic disease
• Previous falls, fractures or conditions affecting bone strength or balance
• Use of strong CYP2C8 or CYP3A4 inhibitors or inducers and medicines with a narrow therapeutic index
• Use of over-the-counter products or herbal remedies that may interact with enzalutamide

Enzalutamide is not intended for use in women and may harm an unborn baby. Men taking Glenza 40 mg are usually advised to use effective contraception if their partner may become pregnant, both during treatment and for a period afterwards, as directed by their doctor.

Enzalutamide Side Effects

Common side effects

Many patients experience side effects when starting Glenza enzalutamide capsules, especially during the first months of therapy. Common reactions may include:

• Fatigue, low energy or general tiredness
• Hot flushes
• Increased blood pressure or worsening of existing hypertension
• Headache, dizziness or difficulty concentrating
• Back pain, joint pain or muscle discomfort
• Mild swelling of the hands, ankles or feet
• Mild diarrhea, nausea or reduced appetite

These side effects are often manageable with supportive care or adjustments in overall management, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of enzalutamide are less common but serious and require urgent medical attention. Serious reactions may include:

• Seizures, sudden loss of consciousness or unusual movements
• Severe confusion, strong headache or visual changes
• Very high blood pressure, chest pain or shortness of breath suggesting a cardiovascular event
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Repeated falls, new fractures or sudden severe bone pain

If you experience any of these serious symptoms while taking Glenza 40 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Glenza 40 mg capsules at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the capsules in their original blisters and carton until use to protect them from moisture and light.
• Keep enzalutamide capsules out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Glenza enzalutamide capsules.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Glenza 40 mg enzalutamide capsules at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Glenza 40 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic enzalutamide capsules compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist or urologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed hormonal therapy with transparent conditions and professional handling of each order.

Order Now

Glenza 40 mg enzalutamide capsules are prescription-only anticancer medicines and must be used strictly under the supervision of an experienced oncologist or urologist.
Before you order Glenza 40 mg online, ensure that you have a valid prescription or written treatment plan specifying enzalutamide, the daily dose and the intended duration of therapy.

Select Glenza 40 mg (1 pack / 28 capsules), choose the appropriate quantity, add Glenza to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your healthcare team.